Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Clinical trial NCT01253460 · TERMINATED
Trial details
- NCT number
- NCT01253460
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-22
- Primary completion
- 2018-03-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.